Described herein are compositions and methods for treating Friedreich's Ataxia (FA) using adeno-associated virus (AAV) to deliver therapeutics agents.
Saturday, June 5, 2021
Rescue of central and peripheral neurological phenotype of friedreich's ataxia by intravenous delivery
Application US16/651,617- Assigned to VOYAGER THERAPEUTICS, INC.
Subscribe to:
Posts (Atom)
